(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYNRIAH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYNRIAH

ST13

US500000079314858

Class

5

Filing

79314858

Registration

6610399

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

05/29/2022

Trademark type

Word

Nice classes

5

Filing date

06/02/2021

Registration date

01/11/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/11/2022

Last transaction

01/11/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

PODESTA, GIDETTE

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVARTIS AG

Representatives

Novartis Pharma AG, Trademark Department

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe endocrine systemthe respiratory systemthe musculo-skeletal system and the genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseasesfor the treatment of diseases and disorders caused by bacteriaautoimmune diseases and disorderskidney diseases and disordersdiabetes; pharmaceutical and biological preparationsanti-fungalanti-infectiveantiviral and antibiotic preparations

Publications

History of USPTO decisions and trademark events.

13 publications found

GPNX

NOTIFICATION PROCESSED BY IB

05/29/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/03/2022

FIMP

FINAL DISPOSITION PROCESSED

05/02/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

02/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

01/11/2022

PUBO

PUBLISHED FOR OPPOSITION

10/26/2021

NPUB

NOTICE OF PUBLICATION

10/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/20/2021

DOCK

ASSIGNED TO EXAMINER

09/20/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/20/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/15/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/12/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

07/01/2021

Continuous trademark protection

Get notified about every new filing that threatens MYNRIAH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.